BRPI1007443B8
Urine and serum biomarkers associated with diabetic nephropathy
Abstract
serum and urine biomarkers associated with diabetic nephropathy. use of urine and serum biomarkers in diagnosing diabetic nephropathy, staging diabetic nephropathy, monitoring the progress of diabetic nephropathy and evaluating the effectiveness of treatments for diabetic nephropathy. these markers include urine precursor alpha-2-hs-glycoprotein, urine alpha-1 antitrypsin, urine alpha-1 acid glycoprotein, urine osteopontin, serum osteopontin and its fragments and combinations thereof.
Term
3.3 yearsto projected expiry
Projected expiry 27 January 2030, counted from filing; an application has no term until it is granted.
- Priority
- Filed
- Published
- Today
- Projected expiry
38 members in 15 offices
Priority claims6
| Document | Office | Kind | Date |
|---|---|---|---|
| 14777809 | United States of America | P | |
| 2010000097 | Canada | W | |
| 61147778 | – | – | – |
| PCTCA2010000097 | – | – | – |
| US20090147778P | – | – | – |
| WO2010CA00097 | – | – | – |
Members38
| Document | Office | Kind | |
|---|---|---|---|
| CA2748937A1 | Canada | A1 | |
| US2010197033A1 | United States of America | A1 | |
| WO2010085879A1 | World Intellectual Property Organization (WIPO) | A1 | |
| TW201033616A | Taiwan Province of China | A | |
| US2011079077A1 | United States of America | A1 | |
| US2011086371A1 | United States of America | A1 | |
| EP2391654A1 | European Patent Office (EPO) | A1 | |
| CN102300877A | China | A | |
| MX2011007811A | Mexico | A | |
| JP2012516431A | Japan | A | |
| EP2391654A4 | European Patent Office (EPO) | A4 | |
| US8465980B2 | United States of America | B2 | |
| US8476077B2 | United States of America | B2 | |
| EP2623517A1 | European Patent Office (EPO) | A1 | |
| US2013252267A1 | United States of America | A1 | |
| TWI449910B | Taiwan Province of China | B | |
| CN102300877B | China | B | |
| JP5689426B2 | Japan | B2 | |
| EP2391654B1 | European Patent Office (EPO) | B1 | |
| EP2623517B1 | European Patent Office (EPO) | B1 | |
| DK2391654T3 | Denmark | T3 | |
| PT2391654E | Portugal | E | |
| PT2623517E | Portugal | E | |
| DK2623517T3 | Denmark | T3 | |
| ES2552467T3 | Spain | T3 | |
| ES2552557T3 | Spain | T3 | |
| EP2623517B8 | European Patent Office (EPO) | B8 | |
| PL2391654T3 | Poland | T3 | |
| PL2623517T3 | Poland | T3 | |
| HUE025795T2 | Hungary | T2 | |
| HUE025796T2 | Hungary | T2 | |
| CA2748937C | Canada | C | |
| CY1116893T1 | Cyprus | T1 | |
| CY1117159T1 | Cyprus | T1 | |
| BRPI1007443A2 | Brazil | A2 | |
| US10101340B2 | United States of America | B2 | |
| BRPI1007443B1 | Brazil | B1 | |
| BRPI1007443B8This record | Brazil | B8 |
5 legal events, as the office reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | |
|---|---|---|
| Patent or certificate of addition of invention grantedGrantedB16A | B16A | |
| Decision: intention to grantB09A | B09A | |
| Requested transfer of rights approvedB25A | B25A | |
| Objections, documents and/or translations needed after an examination request according art. 34 industrial property lawB06F | B06F | |
| Formal requirements before examinationB06T | B06T |
Numbers
- Publication
- PI1007443
- Publication, DOCDB
- PI1007443
- Publication, EPODOC
- BRPI1007443
- Application
- 7443
- Application, DOCDB
- PI1007443
- Application, EPODOC
- BR2010PI07443
Titles2
- Portuguese
- método para diagnosticar nefropatia diabética em um indivíduo, método para avaliar a eficácia de um tratamento para nefropatia diabética em um indivíduo, método para determinação do estágio da nefropatia diabética em um indivíduo, método para monitoramento do progresso da nefropatia diabética em um indivíduo, e método para avaliar a eficácia de um tratamento para nefropatia diabética em um indivíduo
- English
- method for diagnosing diabetic nephropathy in an individual, method for evaluating the effectiveness of a treatment for diabetic nephropathy in an individual, method for determining the stage of diabetic nephropathy in an individual, method for monitoring the progress of diabetic nephropathy in an individual, and method to assess the effectiveness of a treatment for diabetic nephropathy in an individual
Classification
- CPC, 8
- G01N33/6893
- G01N2333/4728
- G01N2333/52
- G01N2333/71
- G01N2333/8125
- G01N2800/347
- G01N2800/52
- G01N2800/56
- IPC, 8
- C07K14 47
- C07K14 81
- C07K16 18
- C07K16 38
- C40B30 00
- G01N33 53
- G01N33 573
- G01N33 68